Skip to content
Subscriber Only
Business
Prognosis

Pfizer, Eli Lilly Breakthroughs Provide Hope for Ending Pandemic

  • Euphoria somewhat offset by China trial halt in Brazil
  • At least 13 places already have supply agreements with Pfizer
Video player cover image
Eli Lilly Covid Antibody Drug Gets Emergency FDA Clearance
Updated on

Almost a year into the pandemic, a world facing the unrelenting spread of the coronavirus received a burst of good news, with a vaccine developed by Pfizer Inc. showing “extraordinary” results while an antibody therapy from Eli Lilly & Co. was granted emergency-use authorization in the U.S.

The double shot of progress was somewhat offset by news that the final-stage trial of a frontrunner Chinese vaccine candidate was halted in Brazil due to a serious adverse event, the first time that the Asian nation’s rapidly ascendant shots have met such a setback.